code stringlengths 4 12 | description stringlengths 2 264 | codetype stringclasses 8
values | context stringlengths 160 15.5k |
|---|---|---|---|
92585 | Auditor evoke potent compre | HCPCS | This is in accordance with the findings of Ayache and associates (2000) who concluded that assessment of perilymphatic pressure does not seem to be useful in Meniere's disease. Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease... |
70540 | MRI scan of bone of eye socket, face, and/or neck without contrast | HCPCS | This is in accordance with the findings of Ayache and associates (2000) who concluded that assessment of perilymphatic pressure does not seem to be useful in Meniere's disease. Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease... |
70542 | MRI scan of bone of eye socket, face, and/or neck with contrast | HCPCS | Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease or idiopathic sudden sensori-neural hearing loss did not differ significantly from the pressure in the non-affected and normal hearing ear. In a follow-up study by Ayache et al... |
92588 | PR DISTRT PROD EVOKD OTOACOUSTIC EMSNS COMP/DX EVAL | HCPCS | Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease or idiopathic sudden sensori-neural hearing loss did not differ significantly from the pressure in the non-affected and normal hearing ear. In a follow-up study by Ayache et al... |
92587 | PR DISTORT PRODUCT EVOKED OTOACOUSTIC EMISNS LIMITD | HCPCS | Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease or idiopathic sudden sensori-neural hearing loss did not differ significantly from the pressure in the non-affected and normal hearing ear. In a follow-up study by Ayache et al... |
92585 | Auditor evoke potent compre | HCPCS | Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease or idiopathic sudden sensori-neural hearing loss did not differ significantly from the pressure in the non-affected and normal hearing ear. In a follow-up study by Ayache et al... |
70540 | MRI scan of bone of eye socket, face, and/or neck without contrast | HCPCS | Furthermore, Rosingh and co-workers (2000) reported that perilymphatic pressure measured in the affected ear of patients with Meniere's disease or idiopathic sudden sensori-neural hearing loss did not differ significantly from the pressure in the non-affected and normal hearing ear. In a follow-up study by Ayache et al... |
70542 | MRI scan of bone of eye socket, face, and/or neck with contrast | HCPCS | In a follow-up study by Ayache et al (2002), the authors concluded that perilymphatic pressure measurements by means of the Tympanic Displacement Analyzer are not useful in the evaluation of patients with Meniere’s disease. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
92588 | PR DISTRT PROD EVOKD OTOACOUSTIC EMSNS COMP/DX EVAL | HCPCS | In a follow-up study by Ayache et al (2002), the authors concluded that perilymphatic pressure measurements by means of the Tympanic Displacement Analyzer are not useful in the evaluation of patients with Meniere’s disease. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
92587 | PR DISTORT PRODUCT EVOKED OTOACOUSTIC EMISNS LIMITD | HCPCS | In a follow-up study by Ayache et al (2002), the authors concluded that perilymphatic pressure measurements by means of the Tympanic Displacement Analyzer are not useful in the evaluation of patients with Meniere’s disease. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
92585 | Auditor evoke potent compre | HCPCS | In a follow-up study by Ayache et al (2002), the authors concluded that perilymphatic pressure measurements by means of the Tympanic Displacement Analyzer are not useful in the evaluation of patients with Meniere’s disease. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
70540 | MRI scan of bone of eye socket, face, and/or neck without contrast | HCPCS | In a follow-up study by Ayache et al (2002), the authors concluded that perilymphatic pressure measurements by means of the Tympanic Displacement Analyzer are not useful in the evaluation of patients with Meniere’s disease. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
0516 | HB URG HIM- NEEDLE ASPIRATION | RC | Nephrectomy specimen. H&E stain. ICD-10 C64 ICD-9 189.0 ICD-O: M8312/3 OMIM 144700 605074 DiseasesDB 11245 MedlinePlus 000516 eMedicine med/2002
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney ... |
0516 | HB URG HIM- NEEDLE ASPIRATION | RC | H&E stain. ICD-10 C64 ICD-9 189.0 ICD-O: M8312/3 OMIM 144700 605074 DiseasesDB 11245 MedlinePlus 000516 eMedicine med/2002
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood ... |
1000 | HC ASAM LEVEL 3.7 MEDICALLY MONITORED INPATIENT | RC | Cohort. Male veterans aged ≥65 with T2DM free from age-related comorbidities (CVD, cancer, depression, dementia, frailty related diseases). Divided into Health class, Cancer risk class, CVD risk class, Frailty risk class.||Overall: Healthy = 22,841/NR, Cancer risk = 4,669/NR, CVD risk = 6,697/NR, Frailty risk = 6,697/N... |
1000 | HC ASAM LEVEL 3.7 MEDICALLY MONITORED INPATIENT | RC | Divided into Health class, Cancer risk class, CVD risk class, Frailty risk class.||Overall: Healthy = 22,841/NR, Cancer risk = 4,669/NR, CVD risk = 6,697/NR, Frailty risk = 6,697/NR||Dementia diagnosis (ICD9:290.xx)|
|Guo ||Metformin (starting dose 0.5 g per tablet, two tablets a day, increasing up to 2.0 g/day to achi... |
83655 | Lead level | HCPCS | However, these tests are not routinely available, and are not recommended by the Centers for Disease Control and Prevention (CDC). BLLs remain the gold standard for the diagnosis of lead poisoning in children”. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for clarificatio... |
83655 | Lead level | HCPCS | BLLs remain the gold standard for the diagnosis of lead poisoning in children”. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for clarification purposes. Codes requiring a 7th character are represented by "+":|
|ICD-10 codes will become effective as of October 1, 2015:|
|C... |
88145 | Cytopath, c/v, thin lyr sel | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
87620 | Hpv dna dir probe | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88148 | Cytopath c/v auto rescreen | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88153 | Cytopath c/v redo | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
87621 | Hpv dna amp probe | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
87622 | Hpv dna quant | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88147 | Cytopath c/v automated | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88165 | Cytopath tbs c/v redo | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
P3000 | Screen pap by tech w md supv | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0123 | SCREENING CYTOPATHOLOGY, CERVICAL OR VAGINAL (ANY REPORTING SYSTEM), COLLECTED IN PRESERVATIVE FLUID, AUTOMATED THIN LAYER PREPARATION, SCREENING BY CYTOTECHNOLOGIST UNDER PHYSICIAN SUPERVISION | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
G0147 | Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
P3001 | Screening pap smear by phys | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88164 | HC CYTOPATHOLOGY, SLIDES, CERVICAL OR VAGINAL; MANUAL SCREENING | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88144 | Cytopath, c/v, thin lyr redo | HCPCS | Primary screening and rescreening of Pap smears using the FocalPointTM system automated slide reading system in high-risk patients (e.g., symptomatic patients, those with prior abnormalities or malignancies, or those with prior abnormal Pap diagnoses) is investigational. HPV testing of Pap Smears to detect high and low... |
88145 | Cytopath, c/v, thin lyr sel | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
87620 | Hpv dna dir probe | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88174 | Cytopath c/v auto in fluid | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88148 | Cytopath c/v auto rescreen | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88153 | Cytopath c/v redo | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
87621 | Hpv dna amp probe | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
87622 | Hpv dna quant | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88147 | Cytopath c/v automated | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88165 | Cytopath tbs c/v redo | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
P3000 | Screen pap by tech w md supv | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0123 | SCREENING CYTOPATHOLOGY, CERVICAL OR VAGINAL (ANY REPORTING SYSTEM), COLLECTED IN PRESERVATIVE FLUID, AUTOMATED THIN LAYER PREPARATION, SCREENING BY CYTOTECHNOLOGIST UNDER PHYSICIAN SUPERVISION | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
G0147 | Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
P3001 | Screening pap smear by phys | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88164 | HC CYTOPATHOLOGY, SLIDES, CERVICAL OR VAGINAL; MANUAL SCREENING | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88144 | Cytopath, c/v, thin lyr redo | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88175 | PAP | HCPCS | POLICY EXCEPTIONSFor Federal Employee Program (FEP) subscribers only, HPV testing, in conjunction with Pap smears, for the purpose of screening women for cervical abnormalities in women over age 30 may be considered medically necessary. The coverage guidelines outlined in the Medical Policy Manual should not be used in... |
88145 | Cytopath, c/v, thin lyr sel | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
87620 | Hpv dna dir probe | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88174 | Cytopath c/v auto in fluid | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88148 | Cytopath c/v auto rescreen | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88153 | Cytopath c/v redo | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
87621 | Hpv dna amp probe | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
87622 | Hpv dna quant | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88147 | Cytopath c/v automated | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88165 | Cytopath tbs c/v redo | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
P3000 | Screen pap by tech w md supv | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0123 | SCREENING CYTOPATHOLOGY, CERVICAL OR VAGINAL (ANY REPORTING SYSTEM), COLLECTED IN PRESERVATIVE FLUID, AUTOMATED THIN LAYER PREPARATION, SCREENING BY CYTOTECHNOLOGIST UNDER PHYSICIAN SUPERVISION | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
G0147 | Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
P3001 | Screening pap smear by phys | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88164 | HC CYTOPATHOLOGY, SLIDES, CERVICAL OR VAGINAL; MANUAL SCREENING | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88144 | Cytopath, c/v, thin lyr redo | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
88175 | PAP | HCPCS | POLICY HISTORY8/1998: Approved by Medical Policy Advisory Committee (MPAC)
8/21/2002: Policy Guidelines revised, CPT codes 88147, 88148, 88153, 88164, 88165 deleted, HCPCS P3000-P3001 deleted, HCPCS G0123-G0124, G0143-G0145 added
10/17/2005: Code reference section updated; CPT-4: 87620, 87621, 87622, 88147, 88148 added... |
87622 | Hpv dna quant | HCPCS | Code reference section udpated. CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; p... |
P3000 | Screen pap by tech w md supv | HCPCS | Code reference section udpated. CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; p... |
88174 | Cytopath c/v auto in fluid | HCPCS | Code reference section udpated. CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; p... |
P3001 | Screening pap smear by phys | HCPCS | Code reference section udpated. CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; p... |
88175 | PAP | HCPCS | Code reference section udpated. CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; p... |
87622 | Hpv dna quant | HCPCS | CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The f... |
P3000 | Screen pap by tech w md supv | HCPCS | CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The f... |
88174 | Cytopath c/v auto in fluid | HCPCS | CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The f... |
P3001 | Screening pap smear by phys | HCPCS | CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The f... |
88175 | PAP | HCPCS | CPT codes 88174 and 88175; HCPCS P3000 and P3001 added to policy
11/14/2006: Code Reference section updated: CPT code 87622 deleted. 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The f... |
87622 | Hpv dna quant | HCPCS | 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and ... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | 8/28/2007: In situ hybridization (ISH) for HPV testing is considered investigational. 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and ... |
87622 | Hpv dna quant | HCPCS | 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and V72.3. CPT code 87622 was moved from non-covered to covered. Revised the description o... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | 7/22/2008: Policy reviewed, no changes
09/10/2010: Policy reviewed; policy statement unchanged. The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and V72.3. CPT code 87622 was moved from non-covered to covered. Revised the description o... |
87622 | Hpv dna quant | HCPCS | The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and V72.3. CPT code 87622 was moved from non-covered to covered. Revised the description of HCPCS code G0141. 12/30/2010: Policy description updated. Policy title changed from "Monolayer... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | The following ICD-9 codes were added to the Covered Codes Table: 795.00-795.04, 795.06, 795.08, 795.10, 795.11, 795.71, 796.9, V73.81 and V72.3. CPT code 87622 was moved from non-covered to covered. Revised the description of HCPCS code G0141. 12/30/2010: Policy description updated. Policy title changed from "Monolayer... |
87622 | Hpv dna quant | HCPCS | CPT code 87622 was moved from non-covered to covered. Revised the description of HCPCS code G0141. 12/30/2010: Policy description updated. Policy title changed from "Monolayer Slide Preparation and AutoSlide Reading Systems for Cervical Cancer Screening" to "Cervical Cancer Screening Technologies with Pap and HPV." 05/... |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | HCPCS | CPT code 87622 was moved from non-covered to covered. Revised the description of HCPCS code G0141. 12/30/2010: Policy description updated. Policy title changed from "Monolayer Slide Preparation and AutoSlide Reading Systems for Cervical Cancer Screening" to "Cervical Cancer Screening Technologies with Pap and HPV." 05/... |
G6015 | Radiation tx delivery imrt | HCPCS | Added policy statement: IMRT is considered investigational for the treatment of prostate cancer when the above criteria are not met. Policy guidelines updated regarding localized prostate cancer. 12/31/2014: Added the following new 2015 CPT codes to the Code Reference section: 77385 and 77386. Added the following new 2... |
77386 | HC IMRT COMPLEX | HCPCS | Added policy statement: IMRT is considered investigational for the treatment of prostate cancer when the above criteria are not met. Policy guidelines updated regarding localized prostate cancer. 12/31/2014: Added the following new 2015 CPT codes to the Code Reference section: 77385 and 77386. Added the following new 2... |
77385 | HC IMRT SIMPLE | HCPCS | Added policy statement: IMRT is considered investigational for the treatment of prostate cancer when the above criteria are not met. Policy guidelines updated regarding localized prostate cancer. 12/31/2014: Added the following new 2015 CPT codes to the Code Reference section: 77385 and 77386. Added the following new 2... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.